Restart Life Sciences (XCNQ:HEAL) Total Stockholders Equity : C$-0.30 Mil (As of Dec. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Restart Life Sciences Total Stockholders Equity?

Restart Life Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2024 was C$-0.30 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Restart Life Sciences's Book Value per Share for the quarter that ended in Dec. 2024 was C$-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Restart Life Sciences's Debt-to-Equity for the quarter that ended in Dec. 2024 was -0.27.

Restart Life Sciences Total Stockholders Equity Historical Data

The historical data trend for Restart Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Total Stockholders Equity Chart

Restart Life Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

2.66

0.46

0.04

-0.81

-0.30

Restart Life Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															-0.81	-0.96	-1.05	-0.59	-0.30

Restart Life Sciences (XCNQ:HEAL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Restart Life Sciences's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.299	-	0)	/	18.012
	=	-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Restart Life Sciences's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.08	+	0)	/	-0.299
	=	-0.27

Restart Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Restart Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Restart Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (XCNQ:HEAL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NMLSF:USA HN30:Germany

Address

700 - 838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6

Website

https://www.restartlife.co

Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. Its focus is on creating health foods that address the needs of this community. Its flagship developments include natural remedies for individuals on the Autism Spectrum, Specialty Health Foods, Psilocybin Clinical Trial for Fragile X Syndrome, and Orphan Drug Designation (FDA and EMA). The company operates in one industry segment, being research and development of psilocybin, and in one geographic area, being Canada.

Executives

Derek Lloyd Harry Ivany	10% Security Holder, Director, Senior Officer
Steven Feldman	Director
William Rascan	Director, Senior Officer

Restart Life Sciences Headlines

No Headlines